001     1037886
005     20250203103255.0
037 _ _ |a FZJ-2025-01029
100 1 _ |a Kroll, Tina
|0 P:(DE-Juel1)131691
|b 0
|e Corresponding author
|u fzj
111 2 _ |a 62. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin
|c Leipzig
|d 2024-04-10 - 2024-04-13
|w Germany
245 _ _ |a Awake PET with the adenosine A1 receptor radiotracer F-18-CPFPX in rats: Optimization of reference region and route of injection
260 _ _ |c 2024
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a CONFERENCE_POSTER
|2 ORCID
336 7 _ |a Output Types/Conference Poster
|2 DataCite
336 7 _ |a Poster
|b poster
|m poster
|0 PUB:(DE-HGF)24
|s 1738052487_29914
|2 PUB:(DE-HGF)
|x After Call
520 _ _ |a For the adenosine A1 receptor tracer F-18-CPFPX the olfactory bulb is an established reference region in rats. However, quantitative awake PET with radioactive point sources attached to the animal’s head for motion correction might be biased by spill-in from the nasal point source to the olfactory bulb. Moreover, for imaging without any anesthesia, intravenous (i.v.) injection of the tracer is demanding and stressful for the animal. This study investigates the feasibility of the pons as reference region and intraperitoneal (i.p.) tracer injection for quantitative analysis of F-18-CPFPX PET in awake rats. Eight male rats underwent six dynamic PET scans each following either an i.v. or i.p. bolus of F-18-CPFPX. For both conditions, two subsequent scans were performed under awake condition followed by a scan under anesthesia. The outcome parameter BPND determined via the simplified reference-tissue model (reference: olfactory bulb or pons) was evaluated in terms of variability and reproducibility. In-vitro H-3-DPCPX saturation autoradiography of the same animals served for validation of in-vivo outcome parameters.In-vitro Bmax and F-18-CPFPX BPNDpons correlated significantly (all p<0.01) for i.v. (r=0.81-0.86) and i.p. (r=0.81-0.88) injection route for awake and anesthetized condition. Test-retest stability of BPNDpons after i.p. tracer injection performed best when comparing the different conditions and gave reliable results in awake animals with high test-retest correlations (r=0.99, p<0.01) and an acceptable absolute variability (mean over all regions 15.3±5.8%).Quantitative awake small-animal PET imaging with F-18-CPFPX is improved by applying a reference region with lower probability of radioactive spill-in from point sources and practicability can be enhanced by i.p. tracer injection without loss of quantitative accuracy.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
536 _ _ |a NEURON Cofund - ERA NET NEURON in the area of brain-related diseases and disorders of the nervous system (680966)
|0 G:(EU-Grant)680966
|c 680966
|f H2020-HCO-2015
|x 1
700 1 _ |a Miranda, Alan
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Drechsel, Alexandra
|0 P:(DE-Juel1)159581
|b 2
|u fzj
700 1 _ |a Klein, Sabina
|0 P:(DE-Juel1)151362
|b 3
|u fzj
700 1 _ |a Beer, Simone
|0 P:(DE-Juel1)133864
|b 4
|u fzj
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 5
|u fzj
700 1 _ |a Drzezga, Alexander
|0 P:(DE-Juel1)177611
|b 6
|u fzj
700 1 _ |a Verhaeghe, Jeroen
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Elmenhorst, David
|0 P:(DE-Juel1)131679
|b 8
|u fzj
700 1 _ |a Bauer, Andreas
|0 P:(DE-Juel1)131672
|b 9
|u fzj
909 C O |o oai:juser.fz-juelich.de:1037886
|p openaire
|p VDB
|p ec_fundedresources
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131691
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)159581
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 3
|6 P:(DE-Juel1)151362
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)133864
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)177611
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131679
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 9
|6 P:(DE-Juel1)131672
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2024
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-2-20090406
|k INM-2
|l Molekulare Organisation des Gehirns
|x 0
980 _ _ |a poster
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21